Elevance Health stock tumbles on Medicaid, Medicare changes
Elevance Health (ELV) shares lost 11% on Thursday after the health insurance group posted weaker-than-expected third-quarter earnings. The company reported adjusted earnings of $8.37 a share, missing analysts’ consensus forecast of $9.
Ballooning Medicaid costs challenge health insurer Elevance
On Thursday, Elevance Health disclosed in its third quarter earnings release that its medical loss ratio — the amount of premium revenue it spent on medical care — was markedly higher than Wall Street analysts expected, sending its stock price into a tailspin.
Key Takeaways The S&P 500 was essentially flat on Thursday, Oct. 17, closing less than 0.1% lower despite strong retail sales ...
Elevance Health has purchased Carebridge, a manager of "home and community-based services," the health insurer disclosed ...
Elevance Health faces profitability issues, impacting its stock price. See more about ELV stock's cautious hold rating and ...
MT Newswires on MSN15h
Elevance Health Lowers Full-Year Earnings Outlook Following Mixed Third-Quarter ResultsElevance Health (ELV) slashed its full-year earnings outlook on Thursday as the health insurer's third-quarter revenue beat Wall Street estimates while bottom-line results missed expectations amid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback